BioSpace News Archive

Fresenius Medical Care, the world’s leading provider of products and services for people with chronic kidney failure, announced that the company’s Frenova division has enrolled the first participants in its new initiative to develop the largest renal-focused genomic registry in the world.

Zai Lab Secures Exclusive Right to Develop and Commercialize TPX-0022, Turning Point’s MET/SRC/CSF1R Inhibitor, in Greater China

Dr. Reddy’s Laboratories Ltd. announced the launch of Febuxostat Tablets, a therapeutic equivalent generic version of Uloric Tablets approved by the U.S. Food and Drug Administration.

Octapharma announced a satellite symposium and poster presentation at the 14th annual congress of the European Association for Haemophilia and Allied Disorders, which will be held virtually from February 3–5, 2021.

Surface Oncology, a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, announced that Jeff Goater, chief executive officer, will participate in the upcoming H.C. Wainwright Bioconnect 2021 Conference, which will take place January 11–14.

Hard cellulose capsules are one two capsule types; the other being gelatin capsules. Cellulose capsules are also called vegetarian capsules, as they are made from the fibers of plants.

NeuroRx, Inc. and RELIEF THERAPEUTICS Holding AG, and the Quantum Leap Healthcare Collaborative of San Francisco announce that NeuroRx and QLHC have signed a Clinical Trial Participation Agreement for the inclusion of ZYESAMI™ in the I-SPY COVID-19 Clinical Trial.

Quantum computing offers the potential to significantly accelerate and optimize the discovery of future new medicines for patients

Editas Medicine, Inc., a leading genome editing company, announced the U.S. Food and Drug Administration has cleared the initiation of the safety phase of the Company’s EDIT-301 clinical trial, and the Company can begin dosing patients.

Idera Pharmaceuticals, Inc. announced that it will provide a company outlook for 2021 at upcoming conferences.